1. Home
  2. NVNO vs MGLD Comparison

NVNO vs MGLD Comparison

Compare NVNO & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • MGLD
  • Stock Information
  • Founded
  • NVNO 1987
  • MGLD 1996
  • Country
  • NVNO United States
  • MGLD United States
  • Employees
  • NVNO N/A
  • MGLD N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • MGLD Finance/Investors Services
  • Sector
  • NVNO Health Care
  • MGLD Finance
  • Exchange
  • NVNO Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • NVNO 41.0M
  • MGLD 41.9M
  • IPO Year
  • NVNO N/A
  • MGLD N/A
  • Fundamental
  • Price
  • NVNO $3.65
  • MGLD $0.98
  • Analyst Decision
  • NVNO
  • MGLD
  • Analyst Count
  • NVNO 0
  • MGLD 0
  • Target Price
  • NVNO N/A
  • MGLD N/A
  • AVG Volume (30 Days)
  • NVNO 76.7K
  • MGLD 8.9K
  • Earning Date
  • NVNO 05-01-2025
  • MGLD 05-08-2025
  • Dividend Yield
  • NVNO N/A
  • MGLD N/A
  • EPS Growth
  • NVNO N/A
  • MGLD N/A
  • EPS
  • NVNO N/A
  • MGLD N/A
  • Revenue
  • NVNO N/A
  • MGLD $31,204,000.00
  • Revenue This Year
  • NVNO N/A
  • MGLD N/A
  • Revenue Next Year
  • NVNO $409.09
  • MGLD N/A
  • P/E Ratio
  • NVNO N/A
  • MGLD N/A
  • Revenue Growth
  • NVNO N/A
  • MGLD N/A
  • 52 Week Low
  • NVNO $2.03
  • MGLD $0.70
  • 52 Week High
  • NVNO $6.48
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 71.64
  • MGLD 54.95
  • Support Level
  • NVNO $2.61
  • MGLD $0.85
  • Resistance Level
  • NVNO $3.97
  • MGLD $1.06
  • Average True Range (ATR)
  • NVNO 0.22
  • MGLD 0.07
  • MACD
  • NVNO 0.11
  • MGLD 0.01
  • Stochastic Oscillator
  • NVNO 80.00
  • MGLD 66.67

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: